Article
Podcast: Key Value Considerations for Growing BioPharm Product Pipeline
BioPharm International interviews Tarja Mottram, CEO of Action for Results, about a paradigm shift in how we measure and provide evidence for the impact of a product on healthcare outcomes. Posted Feb. 2012.
In part II of this BioPharm International interview, Tarja Mottram, CEO of Action for Results, focuses on “design for value”—a paradigm shift in how the industry measures and provides evidence for the impact of a product on healthcare outcomes. Posted Feb. 2012
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
